POST ACUTE SEQUELAE OF COVID-19
Clinical trials for POST ACUTE SEQUELAE OF COVID-19 explained in plain language.
Never miss a new study
Get alerted when new POST ACUTE SEQUELAE OF COVID-19 trials appear
Sign up with your email to follow new studies for POST ACUTE SEQUELAE OF COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an antiviral pill ease long COVID? new trial investigates
Disease control OngoingThis study tests whether the antiviral drug ensitrelvir can help people with long COVID by targeting leftover virus in the body. About 40 adults with long COVID symptoms will receive either the drug or a placebo for 10 days. Researchers will measure changes in physical health and…
Matched conditions: POST ACUTE SEQUELAE OF COVID-19
Phase: PHASE2 • Sponsor: Timothy Henrich • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Zap away brain fog: home device tested for long COVID thinking problems
Symptom relief OngoingThis study tested whether a safe, low-intensity brain stimulation device used at home could improve thinking problems like poor focus and slow processing in people with long COVID. About 31 adults with persistent brain fog used the device for 4 weeks. Researchers measured changes…
Matched conditions: POST ACUTE SEQUELAE OF COVID-19
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 12, 2026 13:39 UTC
-
New test aims to forecast COVID-19 Patients' future health
Knowledge-focused OngoingThis study aims to create a test that can predict how hospitalized COVID-19 patients will fare in the short and long term (up to one year). Researchers will enroll 600 adults from hospitals and Veterans' populations, using both clinical data and molecular markers. The goal is to …
Matched conditions: POST ACUTE SEQUELAE OF COVID-19
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated May 12, 2026 13:39 UTC